Adverse drug interaction between risperidone and carbamazepine in a patient with chronic schizophrenia and deficient CYP2D6 activity

J Clin Psychopharmacol. 2001 Feb;21(1):108-9. doi: 10.1097/00004714-200102000-00020.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antimanic Agents / adverse effects
  • Antimanic Agents / therapeutic use
  • Antipsychotic Agents / adverse effects
  • Antipsychotic Agents / therapeutic use
  • Carbamazepine / adverse effects*
  • Carbamazepine / therapeutic use
  • Chronic Disease
  • Cytochrome P-450 CYP2D6 / deficiency
  • Cytochrome P-450 CYP2D6 / metabolism*
  • Drug Interactions
  • Drug Therapy, Combination
  • Humans
  • Male
  • Risperidone / adverse effects*
  • Risperidone / therapeutic use
  • Schizophrenia / drug therapy
  • Schizophrenia / enzymology*

Substances

  • Antimanic Agents
  • Antipsychotic Agents
  • Carbamazepine
  • Cytochrome P-450 CYP2D6
  • Risperidone